{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.198.11.1142","meta":{"versionId":"6","lastUpdated":"2019-03-15T01:00:14.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.198.11.1142","version":"20190315","name":"Opiate Antagonists","status":"active","date":"2019-03-15T01:00:14-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","concept":[{"code":"HZ90ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Nicotine Replacement"},{"code":"HZ91ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Methadone Maintenance"},{"code":"HZ92ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Levo-alpha-acetyl-methadol (LAAM)"},{"code":"HZ93ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Antabuse"},{"code":"HZ94ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Naltrexone"},{"code":"HZ95ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Naloxone"},{"code":"HZ96ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Clonidine"},{"code":"HZ97ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Bupropion"},{"code":"HZ98ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Psychiatric Medication"},{"code":"HZ99ZZZ","display":"Pharmacotherapy for Substance Abuse Treatment, Other Replacement Medication"}]}]}}